CYTK
Price
$46.37
Change
-$1.41 (-2.95%)
Updated
Dec 18, 04:59 PM (EDT)
64 days until earnings call
MRVI
Price
$5.57
Change
-$0.23 (-3.97%)
Updated
Dec 18, 04:59 PM (EDT)
63 days until earnings call
Ad is loading...

CYTK vs MRVI

Header iconCYTK vs MRVI Comparison
Open Charts CYTK vs MRVIBanner chart's image
Cytokinetics
Price$46.37
Change-$1.41 (-2.95%)
Volume$21.36K
CapitalizationN/A
Maravai LifeSciences Holdings
Price$5.57
Change-$0.23 (-3.97%)
Volume$25.76K
CapitalizationN/A
CYTK vs MRVI Comparison Chart
Loading...
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRVI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CYTK vs. MRVI commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYTK is a Hold and MRVI is a StrongBuy.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (CYTK: $47.78 vs. MRVI: $5.80)
Brand notoriety: CYTK and MRVI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CYTK: 117% vs. MRVI: 122%
Market capitalization -- CYTK: $5.47B vs. MRVI: $823.4M
CYTK [@Biotechnology] is valued at $5.47B. MRVI’s [@Biotechnology] market capitalization is $823.4M. The market cap for tickers in the [@Biotechnology] industry ranges from $482.1B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYTK’s FA Score shows that 1 FA rating(s) are green whileMRVI’s FA Score has 1 green FA rating(s).

  • CYTK’s FA Score: 1 green, 4 red.
  • MRVI’s FA Score: 1 green, 4 red.
According to our system of comparison, CYTK is a better buy in the long-term than MRVI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYTK’s TA Score shows that 3 TA indicator(s) are bullish while MRVI’s TA Score has 5 bullish TA indicator(s).

  • CYTK’s TA Score: 3 bullish, 6 bearish.
  • MRVI’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, MRVI is a better buy in the short-term than CYTK.

Price Growth

CYTK (@Biotechnology) experienced а -5.48% price change this week, while MRVI (@Biotechnology) price change was -2.11% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.92%, and the average quarterly price growth was +0.65%.

Reported Earning Dates

CYTK is expected to report earnings on Feb 20, 2025.

MRVI is expected to report earnings on Feb 19, 2025.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CYTK($5.47B) has a higher market cap than MRVI($823M). MRVI YTD gains are higher at: -11.374 vs. CYTK (-42.772). MRVI has higher annual earnings (EBITDA): 548M vs. CYTK (-481.94M). CYTK has more cash in the bank: 1.01B vs. MRVI (578M). MRVI has less debt than CYTK: MRVI (561M) vs CYTK (790M). MRVI has higher revenues than CYTK: MRVI (277M) vs CYTK (3.22M).
CYTKMRVICYTK / MRVI
Capitalization5.47B823M665%
EBITDA-481.94M548M-88%
Gain YTD-42.772-11.374376%
P/E RatioN/AN/A-
Revenue3.22M277M1%
Total Cash1.01B578M175%
Total Debt790M561M141%
FUNDAMENTALS RATINGS
CYTK: Fundamental Ratings
CYTK
OUTLOOK RATING
1..100
5
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
48
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
57
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CYTKMRVI
RSI
ODDS (%)
Bearish Trend 6 days ago
82%
Bullish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
76%
Momentum
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
75%
MACD
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
68%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 8 days ago
81%
Bullish Trend 9 days ago
78%
Declines
ODDS (%)
Bearish Trend 6 days ago
76%
Bearish Trend 7 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Ad is loading...
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRVI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
EWZ24.000.39
+1.66%
iShares MSCI Brazil ETF
WRND30.24N/A
N/A
NYLI Global Equity R&D Leaders ETF
GURU51.62-0.31
-0.60%
Global X Guru™ ETF
XSW202.23-1.37
-0.67%
SPDR® S&P Software & Services ETF
FTXN28.60-0.20
-0.69%
First Trust Nasdaq Oil & Gas ETF

MRVI and

Correlation & Price change

A.I.dvisor indicates that over the last year, MRVI has been loosely correlated with OCEA. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if MRVI jumps, then OCEA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRVI
1D Price
Change %
MRVI100%
+4.03%
OCEA - MRVI
35%
Loosely correlated
-2.34%
AXON - MRVI
34%
Loosely correlated
-2.09%
VCYT - MRVI
33%
Loosely correlated
-2.52%
CYTK - MRVI
30%
Poorly correlated
-2.53%
SRPT - MRVI
30%
Poorly correlated
-0.81%
More